Breaking News Instant updates and real-time market news.

OTLY

Oatly Group

$3.30 /

+0.035 (+1.07%)

05:48
09/13/22
09/13
05:48
09/13/22
05:48

Oatly Group downgraded to Neutral from Outperform at Credit Suisse

Credit Suisse analyst Kaumil Gajrawala downgraded Oatly Group to Neutral from Outperform with a price target of $3.43, down from $6. The analyst expects a "particularly volatile consumer environment" in Europe and Asia. Inflation and "unpredictable lockdowns" have already hurt Oatly's ability to compete against peers with more capacity, Gajrawala tells investors in a research note. The analyst believes these headwinds will strengthen with colder months ahead, delaying the company's growth and margin story "yet again."

OTHER BREAKING NEWS FROM THE FLY

Recommendations
BP price target raised to 650 GBp from 550 GBp at RBC Capital » 09:18
02/08/23
02/08
09:18
02/08/23
09:18
BP

BP

$37.73 /

+2.91 (+8.36%)

RBC Capital analyst Biraj…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BP BP
$37.73 /

+2.91 (+8.36%)

BP BP
$37.73 /

+2.91 (+8.36%)

06:25 Today Bernstein
BP price target raised to $53 from $48 at Bernstein
02/07/23 TD Securities
BP upgraded to Buy from Hold at TD Securities
01/23/23 Morgan Stanley
BP price target raised to 636 GBp from 603 GBp at Morgan Stanley
01/19/23 JPMorgan
BP price target lowered to 540 GBp from 560 GBp at JPMorgan
BP BP
$37.73 /

+2.91 (+8.36%)

BP BP
$37.73 /

+2.91 (+8.36%)

BP BP
$37.73 /

+2.91 (+8.36%)

BP BP
$37.73 /

+2.91 (+8.36%)

Recommendations
Inspire Medical price target raised to $305 from $250 at Lake Street » 09:17
02/08/23
02/08
09:17
02/08/23
09:17
INSP

Inspire Medical

$249.33 /

+5.91 (+2.43%)

Lake Street analyst Frank…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INSP Inspire Medical
$249.33 /

+5.91 (+2.43%)

INSP Inspire Medical
$249.33 /

+5.91 (+2.43%)

07:45 Today Truist
Inspire Medical price target raised to $330 from $310 at Truist
04:30 Today Piper Sandler
Inspire Medical price target raised to $305 from $300 at Piper Sandler
01/31/23 Truist
Inspire Medical price target raised to $310 from $308 at Truist
01/31/23 Lake Street
CVRx initiated with a Buy at Lake Street
INSP Inspire Medical
$249.33 /

+5.91 (+2.43%)

  • 12
    Aug
INSP Inspire Medical
$249.33 /

+5.91 (+2.43%)

Hot Stocks
Avantax appoints Melissa Loner as CCO » 09:16
02/08/23
02/08
09:16
02/08/23
09:16
AVTA

Avantax

$29.20 /

+0.365 (+1.27%)

Avantax announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVTA Avantax
$29.20 /

+0.365 (+1.27%)

AVTA Avantax
$29.20 /

+0.365 (+1.27%)

Recommendations
Catalent price target raised to $85 from $73 at RBC Capital » 09:16
02/08/23
02/08
09:16
02/08/23
09:16
CTLT

Catalent

$71.55 /

+4.545 (+6.78%)

RBC Capital analyst Sean…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CTLT Catalent
$71.55 /

+4.545 (+6.78%)

CTLT Catalent
$71.55 /

+4.545 (+6.78%)

08:22 Today BofA
Catalent price target raised to $78 from $60 at BofA
07:10 Today Baird
Catalent price target raised to $82 from $75 at Baird
05:25 Today Barclays
Catalent price target raised to $82 from $58 at Barclays
02/06/23 Jefferies
Jefferies says Catalent could be valued near $93 on average CDMO buyout multiple
CTLT Catalent
$71.55 /

+4.545 (+6.78%)

CTLT Catalent
$71.55 /

+4.545 (+6.78%)

CTLT Catalent
$71.55 /

+4.545 (+6.78%)

CTLT Catalent
$71.55 /

+4.545 (+6.78%)

Hot Stocks
NeuroSense receives approval in Germany to enroll patients in Paradigm study » 09:16
02/08/23
02/08
09:16
02/08/23
09:16
NRSN

NeuroSense

$1.55 /

-0.02 (-1.27%)

NeuroSense Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NRSN NeuroSense
$1.55 /

-0.02 (-1.27%)

Recommendations
Illumina price target lowered to $235 from $285 at Stifel » 09:15
02/08/23
02/08
09:15
02/08/23
09:15
ILMN

Illumina

$215.71 /

+7.085 (+3.40%)

Stifel analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ILMN Illumina
$215.71 /

+7.085 (+3.40%)

ILMN Illumina
$215.71 /

+7.085 (+3.40%)

08:00 Today RBC Capital
Illumina price target raised to $303 from $284 at RBC Capital
07:58 Today BofA
Illumina price target raised to $230 from $210 at BofA
05:32 Today Barclays
Illumina price target lowered to $150 from $160 at Barclays
01/27/23 Piper Sandler
Illumina price target lowered to $290 from $300 at Piper Sandler
ILMN Illumina
$215.71 /

+7.085 (+3.40%)

ILMN Illumina
$215.71 /

+7.085 (+3.40%)

ILMN Illumina
$215.71 /

+7.085 (+3.40%)

ILMN Illumina
$215.71 /

+7.085 (+3.40%)

Hot Stocks
TELEMEDICUS Inc. trading halted, news pending  09:13
02/08/23
02/08
09:13
02/08/23
09:13
TMDI

Titan Medical

/

+

 
ShowHide Related Items >><<
TMDI Titan Medical
/

+

TMDI Titan Medical
/

+

03/25/22 Oppenheimer
Titan Medical downgraded to Perform from Outperform at Oppenheimer
03/25/22 Oppenheimer
Titan Medical downgraded to Perform from Outperform at Oppenheimer
TMDI Titan Medical
/

+

Upgrade
Guangshen Railway upgraded to Buy from Hold at Jefferies » 09:11
02/08/23
02/08
09:11
02/08/23
09:11
GNGYF

Guangshen Railway

/

+

Jefferies analyst Hengli…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
EnWave announces partner plans to launch new seafood snack pack in 2023 » 09:10
02/08/23
02/08
09:10
02/08/23
09:10
NWVCF

EnWave

/

+

EnWave Corporatio…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NWVCF EnWave
/

+

NWVCF EnWave
/

+

06/01/22 Raymond James
EnWave downgraded to Market Perform from Outperform at Raymond James
NWVCF EnWave
/

+

Hot Stocks
Celanese expanding portfolio of sustainable products across Acetyl Chain » 09:10
02/08/23
02/08
09:10
02/08/23
09:10
CE

Celanese

$123.94 /

+2.02 (+1.66%)

Celanese announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CE Celanese
$123.94 /

+2.02 (+1.66%)

CE Celanese
$123.94 /

+2.02 (+1.66%)

01/05/23 Barclays
Axalta Coating price target raised to $30 from $28 at Barclays
01/04/23 RBC Capital
Celanese upgraded to Outperform from Sector Perform at RBC Capital
12/19/22 Barclays
Celanese price target raised to $150 from $133 at Barclays
12/15/22 Citi
Celanese price target raised to $111 from $96 at Citi
CE Celanese
$123.94 /

+2.02 (+1.66%)

Hot Stocks
LivaNova announces limited commercial release for Essenz Perfusion System » 09:09
02/08/23
02/08
09:09
02/08/23
09:09
LIVN

LivaNova

$55.67 /

+0.88 (+1.61%)

LivaNova announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LIVN LivaNova
$55.67 /

+0.88 (+1.61%)

LIVN LivaNova
$55.67 /

+0.88 (+1.61%)

02/07/23 Piper Sandler
LivaNova tells Piper FDA clinical trial website update incorrect
12/21/22 Barclays
LivaNova initiated with an Equal Weight at Barclays
11/02/22 Piper Sandler
LivaNova price target lowered to $84 from $94 at Piper Sandler
08/03/22 Piper Sandler
LivaNova price target lowered to $94 from $99 at Piper Sandler
LIVN LivaNova
$55.67 /

+0.88 (+1.61%)

Hot Stocks
CVS Health says Oak Street Health deal has long term growth, earnings power » 09:09
02/08/23
02/08
09:09
02/08/23
09:09
CVS

CVS Health

$86.02 /

+0.77 (+0.90%)

, OSH

Oak Street Health

$33.67 /

+7.64 (+29.35%)

Expects to maintain…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CVS CVS Health
$86.02 /

+0.77 (+0.90%)

OSH Oak Street Health
$33.67 /

+7.64 (+29.35%)

CVS CVS Health
$86.02 /

+0.77 (+0.90%)

08:07 Today Piper Sandler
Oak Street Health downgraded to Neutral from Overweight at Piper Sandler
07:36 Today Stifel
Oak Street Health downgraded to Hold from Buy at Stifel
02/07/23 Stifel
Oak Street Health price target raised to $39 from $35 at Stifel
02/07/23 Piper Sandler
Oak Street 'particularly attractive' in current environment, says Piper Sandler
OSH Oak Street Health
$33.67 /

+7.64 (+29.35%)

08:26 Today Evercore ISI
Oak Street Health downgraded to In Line from Outperform at Evercore ISI
08:07 Today Piper Sandler
Oak Street Health downgraded to Neutral from Overweight at Piper Sandler
07:36 Today Stifel
Oak Street Health downgraded to Hold from Buy at Stifel
02/07/23 Stifel
Oak Street Health price target raised to $39 from $35 at Stifel
CVS CVS Health
$86.02 /

+0.77 (+0.90%)

OSH Oak Street Health
$33.67 /

+7.64 (+29.35%)

  • 17
    Aug
CVS CVS Health
$86.02 /

+0.77 (+0.90%)

OSH Oak Street Health
$33.67 /

+7.64 (+29.35%)

CVS CVS Health
$86.02 /

+0.77 (+0.90%)

OSH Oak Street Health
$33.67 /

+7.64 (+29.35%)

CVS CVS Health
$86.02 /

+0.77 (+0.90%)

OSH Oak Street Health
$33.67 /

+7.64 (+29.35%)

Hot Stocks
Vital Farms appoints Wrede as Chief Financial Officer » 09:08
02/08/23
02/08
09:08
02/08/23
09:08
VITL

Vital Farms

$16.87 /

-0.18 (-1.06%)

Vital Farms is adding a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VITL Vital Farms
$16.87 /

-0.18 (-1.06%)

VITL Vital Farms
$16.87 /

-0.18 (-1.06%)

09/30/22 UBS
Vital Farms initiated with a Buy at UBS
07/20/22 Morgan Stanley
Vital Farms upgraded to Overweight from Equal Weight at Morgan Stanley
05/06/22 BMO Capital
Vital Farms price target lowered to $15 from $20 at BMO Capital
VITL Vital Farms
$16.87 /

-0.18 (-1.06%)

Initiation
Alithya Group initiated with an Outperform at Barrington » 09:07
02/08/23
02/08
09:07
02/08/23
09:07
ALYA

Alithya Group

$1.76 /

-0.01 (-0.56%)

Barrington analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALYA Alithya Group
$1.76 /

-0.01 (-0.56%)

ALYA Alithya Group
$1.76 /

-0.01 (-0.56%)

12/21/22 Scotiabank
Alithya Group assumed with a Sector Perform at Scotiabank
11/11/22 BMO Capital
Alithya Group price target lowered to C$3 from C$3.50 at BMO Capital
10/28/22 National Bank
Alithya Group initiated with a Sector Perform at National Bank
09/07/22 BMO Capital
Alithya Group initiated with a Market Perform at BMO Capital
Earnings
Natural Health Trends reports Q4 EPS 2c vs. 2c last year » 09:07
02/08/23
02/08
09:07
02/08/23
09:07
NHTC

Natural Health Trends

$4.77 /

-0.07 (-1.45%)

Reports Q4 revenue $12.5M…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NHTC Natural Health Trends
$4.77 /

-0.07 (-1.45%)

Hot Stocks
Digital subsidiary announces Goodcents' plan to maintain certified clean progam » 09:07
02/08/23
02/08
09:07
02/08/23
09:07
DGLY

Digital Ally

$5.75 /

-1.456 (-20.21%)

Shield Products, a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DGLY Digital Ally
$5.75 /

-1.456 (-20.21%)

Recommendations
Stephens keeps Equal Weight on Green Plains, estimates under review after Q4 » 09:06
02/08/23
02/08
09:06
02/08/23
09:06
GPRE

Green Plains

$33.96 /

-0.24 (-0.70%)

Stephens analyst Ben…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GPRE Green Plains
$33.96 /

-0.24 (-0.70%)

GPRE Green Plains
$33.96 /

-0.24 (-0.70%)

01/17/23 Stephens
Green Plains downgraded to Equal Weight from Overweight at Stephens
12/14/22 UBS
Green Plains initiated with a Buy at UBS
12/13/22 UBS
Green Plains initiated with a Buy at UBS
10/24/22 BofA
Green Plains price target lowered to $35 from $43 at BofA
GPRE Green Plains
$33.96 /

-0.24 (-0.70%)

GPRE Green Plains
$33.96 /

-0.24 (-0.70%)

GPRE Green Plains
$33.96 /

-0.24 (-0.70%)

Earnings
Pioneer Power expects FY22 revenue to exceed $27.5M » 09:06
02/08/23
02/08
09:06
02/08/23
09:06
PPSI

Pioneer Power

$2.89 /

-0.08 (-2.69%)

Pioneer Power Solutions…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PPSI Pioneer Power
$2.89 /

-0.08 (-2.69%)

PPSI Pioneer Power
$2.89 /

-0.08 (-2.69%)

10/12/22 H.C. Wainwright
Pioneer Power contract shows share gains continue, says H.C. Wainwright
Recommendations
Model N price target raised to $52 from $45 at Truist » 09:06
02/08/23
02/08
09:06
02/08/23
09:06
MODN

Model N

$40.82 /

+0.555 (+1.38%)

, ABBV

AbbVie

$145.14 /

+0.12 (+0.08%)

, MRNA

Moderna

$171.07 /

+0.755 (+0.44%)

Truist analyst Terry…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MODN Model N
$40.82 /

+0.555 (+1.38%)

ABBV AbbVie
$145.14 /

+0.12 (+0.08%)

MRNA Moderna
$171.07 /

+0.755 (+0.44%)

MODN Model N
$40.82 /

+0.555 (+1.38%)

11/09/22 Needham
Model N price target raised to $42 from $34 at Needham
11/09/22 Truist
Model N price target raised to $45 from $35 at Truist
11/09/22 Craig-Hallum
Model N price target raised to $42 from $34 at Craig-Hallum
11/09/22 JMP Securities
Model N price target raised to $46 from $39 at JMP Securities
ABBV AbbVie
$145.14 /

+0.12 (+0.08%)

01/26/23 JPMorgan
AbbVie recent weakness a buying opportunity, says JPMorgan
01/05/23 Truist
AbbVie price target raised to $180 from $160 at Truist
11/17/22 Credit Suisse
AbbVie initiated with an Outperform at Credit Suisse
11/08/22 Societe Generale
AbbVie downgraded at Societe Generale on blood cancer and aesthetics headwinds
MRNA Moderna
$171.07 /

+0.755 (+0.44%)

07:10 Today Baird
Catalent price target raised to $82 from $75 at Baird
02/06/23 Needham
Personalis upgraded to Buy at Needham on cost reductions, biopharma potential
01/25/23 Cowen
Moderna price target raised to $150 from $130 at Cowen
01/18/23 Chardan
Moderna price target raised to $208 from $191 at Chardan
MODN Model N
$40.82 /

+0.555 (+1.38%)

ABBV AbbVie
$145.14 /

+0.12 (+0.08%)

MRNA Moderna
$171.07 /

+0.755 (+0.44%)

ABBV AbbVie
$145.14 /

+0.12 (+0.08%)

MRNA Moderna
$171.07 /

+0.755 (+0.44%)

MODN Model N
$40.82 /

+0.555 (+1.38%)

ABBV AbbVie
$145.14 /

+0.12 (+0.08%)

MRNA Moderna
$171.07 /

+0.755 (+0.44%)

ABBV AbbVie
$145.14 /

+0.12 (+0.08%)

MRNA Moderna
$171.07 /

+0.755 (+0.44%)

Hot Stocks
NFL selects Verizon Business for private wireless solution » 09:05
02/08/23
02/08
09:05
02/08/23
09:05
VZ

Verizon

$40.56 /

-0.74 (-1.79%)

Verizon, an Official…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VZ Verizon
$40.56 /

-0.74 (-1.79%)

VZ Verizon
$40.56 /

-0.74 (-1.79%)

02/07/23 LightShed Partners
AT&T downgraded to Neutral from Buy at LightShed Partners
02/06/23 MoffettNathanson
T-Mobile downgraded at MoffettNathanson amid 'great deceleration'
01/26/23 Citi
Verizon price target raised to $42 from $39 at Citi
01/25/23 Cowen
Verizon price target lowered to $49 from $55 at Cowen
VZ Verizon
$40.56 /

-0.74 (-1.79%)

VZ Verizon
$40.56 /

-0.74 (-1.79%)

VZ Verizon
$40.56 /

-0.74 (-1.79%)

VZ Verizon
$40.56 /

-0.74 (-1.79%)

Recommendations
Haemonetics price target raised to $103 from $94 at Barrington » 09:05
02/08/23
02/08
09:05
02/08/23
09:05
HAE

Haemonetics

$82.55 /

-5.435 (-6.18%)

Barrington analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HAE Haemonetics
$82.55 /

-5.435 (-6.18%)

HAE Haemonetics
$82.55 /

-5.435 (-6.18%)

06:39 Today Mizuho
Haemonetics price target raised to $115 from $110 at Mizuho
01/24/23 Mizuho
Haemonetics price target raised to $110 from $100 at Mizuho
12/12/22 Citi
Haemonetics price target raised to $92 from $88 at Citi
11/08/22 Barrington
Haemonetics price target raised to $94 from $88 at Barrington
HAE Haemonetics
$82.55 /

-5.435 (-6.18%)

HAE Haemonetics
$82.55 /

-5.435 (-6.18%)

Hot Stocks
Nano Dimension announces new patent for cloud manufacturing platform » 09:05
02/08/23
02/08
09:05
02/08/23
09:05
NNDM

Nano Dimension

$2.61 /

-0.085 (-3.15%)

Nano Dimension announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NNDM Nano Dimension
$2.61 /

-0.085 (-3.15%)

NNDM Nano Dimension
$2.61 /

-0.085 (-3.15%)

NNDM Nano Dimension
$2.61 /

-0.085 (-3.15%)

Recommendations
Enanta price target raised to $68 from $56 at H.C. Wainwright » 09:03
02/08/23
02/08
09:03
02/08/23
09:03
ENTA

Enanta

$54.46 /

+1.75 (+3.32%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ENTA Enanta
$54.46 /

+1.75 (+3.32%)

ENTA Enanta
$54.46 /

+1.75 (+3.32%)

12/09/22 H.C. Wainwright
Enanta initiated with a Buy at H.C. Wainwright
11/22/22 RBC Capital
Enanta price target lowered to $54 from $65 at RBC Capital
10/17/22 Piper Sandler
Enanta trial start marks fourth in RSV franchise, says Piper Sandler
08/10/22 Oppenheimer
Enanta price target raised to $59 from $53 at Oppenheimer
ENTA Enanta
$54.46 /

+1.75 (+3.32%)

Hot Stocks
BioRestorative announces notice of allowance by EPO for ThermoStem program » 09:03
02/08/23
02/08
09:03
02/08/23
09:03
BRTX

BioRestorative Therapies

$3.09 /

-0.01 (-0.32%)

BioRestorative Therapies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BRTX BioRestorative Therapies
$3.09 /

-0.01 (-0.32%)

BRTX BioRestorative Therapies
$3.09 /

-0.01 (-0.32%)

12/07/22 Roth Capital
BioRestorative Therapies initiated with a Buy at Roth Capital
09/28/22 Maxim
BioRestorative Therapies initiated with a Buy at Maxim
Recommendations
Trane price target raised to $200 from $185 at Argus » 09:03
02/08/23
02/08
09:03
02/08/23
09:03
TT

Trane

$180.43 /

-4.53 (-2.45%)

Argus analyst John Eade…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TT Trane
$180.43 /

-4.53 (-2.45%)

TT Trane
$180.43 /

-4.53 (-2.45%)

02/03/23 Deutsche Bank
Trane price target raised to $184 from $170 at Deutsche Bank
02/03/23 RBC Capital
Trane price target raised to $177 from $164 at RBC Capital
02/03/23 Mizuho
Trane price target raised to $185 from $175 at Mizuho
01/26/23 OTR Global
U.S. commercial HVAC equipment view upgraded at OTR Global
TT Trane
$180.43 /

-4.53 (-2.45%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.